Literature DB >> 14551601

Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis.

A Barton1, R Lamb, D Symmons, A Silman, W Thomson, J Worthington, R Donn.   

Abstract

The aim of the study was to investigate whether polymorphisms of macrophage migration inhibitory factor (MIF) determine susceptibility to or severity of inflammatory polyarthritis (IP). Genotypes for a single-nucleotide polymorphism (MIF-173*G/C) and a tetranucleotide (CATT)(n) repeat mapping to the promoter region of the MIF gene were compared between UK Caucasian IP cases (n=438) and controls (n=343). Both polymorphisms were also investigated for association with features of disease activity and severity at baseline and by 5 years. The MIF-173*C allele (OR 1.7, 95% CI 1.3-2.4, P=1.8 x 10(-4)) and the CATT(7) allele (OR 1.5, 95% CI 1.0-2.1, P=0.02) were found to be associated with increased susceptibility to IP. Furthermore, presence of the haplotype containing both associated polymorphisms was associated with a three-fold increase risk of developing IP. No association with disease severity or activity either at baseline or by 5 years was detected for either of the promoter polymorphisms studied. In conclusion, MIF is a susceptibility gene for the development of IP. The same alleles previously reported to be associated with susceptibility to juvenile idiopathic arthritis account for the increased risk. The promoter polymorphisms of MIF, investigated in this study, do not influence the severity of disease outcome by 5 years.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14551601     DOI: 10.1038/sj.gene.6364014

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  33 in total

1.  Macrophage migration inhibitory factor and its genetic association with arthritis: a work in progress.

Authors:  Timothy R D J Radstake; Richard Bucala
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

2.  Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.

Authors:  Maria Swanberg; Fiona McGuigan; Kaisa K Ivaska; Paul Gerdhem; Ulf H Lerner; Richard Bucala; George Kuchel; Anne Kenny; Kristina Akesson
Journal:  Bone       Date:  2010-05-12       Impact factor: 4.398

3.  Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia.

Authors:  Zhong-Wu Li; Ying Wu; Yu Sun; Lu-Ying Liu; Meng-Meng Tian; Guo-Shuang Feng; Wei-Cheng You; Ji-You Li
Journal:  World J Gastroenterol       Date:  2010-04-14       Impact factor: 5.742

4.  Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome.

Authors:  Afig Berdeli; Sevgi Mir; Nese Ozkayin; Erkin Serdaroglu; Yilmaz Tabel; Alphan Cura
Journal:  Pediatr Nephrol       Date:  2005-08-16       Impact factor: 3.714

5.  Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.

Authors:  Antoine Sreih; Rana Ezzeddine; Lin Leng; Avery LaChance; Geraldine Yu; Yuka Mizue; Lakshman Subrahmanyan; Bernardo A Pons-Estel; Anna-Karin Abelson; Iva Gunnarsson; Elisabet Svenungsson; Joshua Cavett; Stuart Glenn; Lin Zhang; Ruth Montgomery; Andras Perl; Jane Salmon; Marta E Alarcón-Riquelme; John B Harley; Richard Bucala
Journal:  Arthritis Rheum       Date:  2011-12

6.  Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.

Authors:  C Herder; N Klopp; J Baumert; M Müller; N Khuseyinova; C Meisinger; S Martin; T Illig; W Koenig; B Thorand
Journal:  Diabetologia       Date:  2007-08-22       Impact factor: 10.122

Review 7.  Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.

Authors:  Millicent Winner; Lin Leng; Wayne Zundel; Robert A Mitchell
Journal:  Methods Enzymol       Date:  2007       Impact factor: 1.600

8.  A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.

Authors:  David N Assis; Hiroki Takahashi; Lin Leng; Mikio Zeniya; James L Boyer; Richard Bucala
Journal:  Dig Dis Sci       Date:  2016-10-01       Impact factor: 3.199

9.  Influence of the MIF polymorphism -173G > C on Turkish postmenopausal women with osteoporosis.

Authors:  A Z Ozsoy; N Karakus; S Tural; S Yigit; N Kara; G Alayli; M K Tumer; O Kuru
Journal:  Z Rheumatol       Date:  2018-09       Impact factor: 1.372

10.  Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.

Authors:  Timothy R D J Radstake; Jaap Fransen; Erik J M Toonen; Marieke J H Coenen; Agnes E Eijsbouts; Rachelle Donn; Frank H J van den Hoogen; Piet L C M van Riel
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.